The United States Pharmaceutical Gelatin Market continues to demonstrate strong growth, with its valuation reaching USD 567.8 million in 2024. According to the latest industry analysis, the market is projected to grow at a CAGR of 5.6%, reaching approximately USD 786.4 million by 2030. This growth is largely fueled by increasing demand for soft and hard capsules in drug formulations, a surge in clean-label pharmaceutical products, and ongoing advancements in manufacturing automation that enhance efficiency and scalability.
Pharmaceutical gelatin is a vital product in the healthcare and pharmaceutical industries, primarily used in the manufacturing of soft and hard capsules, coatings for tablets, and various drug delivery applications. Derived from purified collagen sourced from animal materials like bovine hides, pig skin, and bones, it undergoes rigorous processing to meet high pharmaceutical-grade standards. Its natural biocompatibility and gel-forming properties make it ideal for encapsulating active ingredients, providing controlled release, and ensuring safe, effective drug delivery, while industries increasingly prioritize patient-friendly and sustainable options.
Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/281406/united-states-pharmaceutical-gelatin-market
Market Overview & Regional Analysis
The United States leads the North American pharmaceutical gelatin market, benefiting from a robust pharmaceutical sector and stringent regulatory frameworks that emphasize quality and safety. Key drivers include the concentration of manufacturing hubs in regions like the Northeast, Midwest, and South, where major drug producers operate, alongside rising investments in innovative drug delivery systems that rely heavily on gelatin for capsule production and tablet coatings.
Within the U.S., growth is supported by advanced supply chains and compliance with standards such as USP and EP, which ensure product integrity. While domestic production meets much of the demand, imports play a role in supplementing specialized needs, particularly for alternative formulations. Emerging trends in personalized medicine and biologics further bolster the market, though regional variations exist due to differences in healthcare infrastructure and policy support across states.
Key Market Drivers and Opportunities
The market is driven by the rising demand for patient-friendly dosage forms like soft and hard capsules, which account for a significant portion of gelatin usage, alongside the pharmaceutical industry’s shift toward clean-label and non-GMO products. Technological advancements in automation have improved production yields and efficiency, while the focus on advanced drug delivery systems opens new avenues for gelatin in controlled release applications. Furthermore, increasing R&D investments in therapies ranging from pain management to oncology enhance gelatin’s role in innovative formulations.
Opportunities abound in the development of vegetarian and halal-certified alternatives derived from plant sources like agar-agar or pectin, catering to diverse consumer preferences and ethical considerations. The integration of gelatin in micro-encapsulation and absorbable hemostats presents untapped potential, especially as healthcare providers seek biocompatible materials for minimally invasive procedures. Additionally, the growing emphasis on sustainability encourages manufacturers to explore eco-friendly sourcing and processing methods, positioning the U.S. market for expanded innovation and export capabilities.
Challenges & Restraints
The pharmaceutical gelatin market encounters challenges such as ethical and religious concerns over animal-derived sources, which limit acceptance in certain communities and drive demand for synthetic alternatives like HPMC. Raw material price volatility from fluctuating supplies of pig skin, bovine hides, and bones adds cost pressures, while environmental sustainability issues related to production processes prompt stricter regulations. Competition from plant-based substitutes and the need for ongoing compliance with evolving pharmacopeia standards further complicate market dynamics, requiring manufacturers to balance tradition with innovation.
Market Segmentation by Type
- Pig Skin
- Bovine Hides
- Bones
- Others
Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/281406/united-states-pharmaceutical-gelatin-market
Market Segmentation by Application
- Hard Capsules
- Soft Capsules
- Micro-encapsulation
- Coating for Tablets
- Absorbable Hemostat
Market Segmentation and Key Players
- Rousselot
- Gelita AG
- Catalent Pharma Solutions
- Pfizer Inc.
- Merck & Co., Inc.
- GSK (GlaxoSmithKline)
- Johnson & Johnson
- Eli Lilly and Company
- AbbVie Inc.
- Teva Pharmaceuticals
Report Scope
This report presents a comprehensive analysis of the United States and regional markets for Pharmaceutical Gelatin, covering the period from 2024 to 2030. It includes detailed insights into the current market status and outlook across various regions and states, with specific focus on:
-
Sales, sales volume, and revenue forecasts
-
Detailed segmentation by type and application
In addition, the report offers in-depth profiles of key industry players, including:
-
Company profiles
-
Product specifications
-
Production capacity and sales
-
Revenue, pricing, gross margins
-
Sales performance
It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.
As part of this research, we surveyed Pharmaceutical Gelatin companies and industry experts. The survey covered various aspects, including:
-
Revenue and demand trends
-
Product types and recent developments
-
Strategic plans and market drivers
-
Industry challenges, obstacles, and potential risks
Get Full Report Here: https://www.24chemicalresearch.com/reports/281406/united-states-pharmaceutical-gelatin-market
About 24chemicalresearch
Founded in 2015, 24chemicalresearch has rapidly established itself as a leader in chemical market intelligence, serving clients including over 30 Fortune 500 companies. We provide data-driven insights through rigorous research methodologies, addressing key industry factors such as government policy, emerging technologies, and competitive landscapes.
- Plant-level capacity tracking
- Real-time price monitoring
- Techno-economic feasibility studies
With a dedicated team of researchers possessing over a decade of experience, we focus on delivering actionable, timely, and high-quality reports to help clients achieve their strategic goals. Our mission is to be the most trusted resource for market insights in the chemical and materials industries.
International: +1(332) 2424 294 | Asia: +91 9169162030
Website: https://www.24chemicalresearch.com/
Follow us on LinkedIn: https://www.linkedin.com/company/24chemicalresearch
- Top 10 Companies in the Rubber Repair Adhesive Market (2025): Market Leaders in Durable Industrial Bonding Solutions - September 23, 2025
- Segment Analysis of Global High-Durometer Flexographic Printing Plates Market: Products, Applications, and End-Users - September 23, 2025
- 2023-2030 Global and Regional Subsea Risers Industry Status and Prospects Professional Market Research Report Standard Version - September 23, 2025